Validation of a Drug Transporter Probe Cocktail Using the Prototypical Inhibitors Rifampin, Probenecid, Verapamil, and Cimetidine
ConclusionsTaking all the interaction results together, the transporter cocktail is considered to be validated as a sensitive and specific tool for evaluating transporter-mediated drug –drug interactions in drug development.Clinical Trial RegistrationEudraCT number 2017-001549-29.
Source: Clinical Pharmacokinetics - Category: Drugs & Pharmacology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Clinical Trials | Crestor | Drugs & Pharmacology | Fortamet | Furosemide | Metformin | Multidrug Resistance | Oral Cancer | Organic | Rosuvastatin | Study | Verapamil